EUVIMEDEUVIMED entdecken
Open Access · CC BY-NC 4.0

Myotonia congenita in a Greek cohort: Genotype spectrum and impact of the CLCN1 :c. 501C > G variant as a genetic modifier

Nikolaos M Marinakis iD, Maria Svingou iD, Giorgos-Konstantinos Papadimas iD, Constantinos Papadopoulos, Elisabeth Chroni iD, Roser Pons, Evangelos Pavlou, Ioannis Sarmas, Konstantina Kosma, Paraskevi Apostolou, Christalena Sofocleous, Joanne Traeger-Synodinos iD und 1 weitere

Muscle & Nerve · 2024

DOI: 10.1002/mus.28180 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Muscle & Nerve, 2024. Verfasst von Nikolaos M Marinakis und 12 weiteren Autor:innen. Beteiligte Einrichtung: Laboratory of Medical Genetics, Medical School, St. Sophia's Children's Hospital, National and Kapodistrian University of Athens, Athens, Greece. Hauptthemen laut MEDLINE: Myotonia Congenita, Chloride Channels, Genotype. Die Arbeit nennt 32 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Introduction/Aims Myotonia congenita (MC) is the most common hereditary channelopathy in humans. Characterized by muscle stiffness, MC may be transmitted as either an autosomal dominant (Thomsen) or a recessive (Becker) disorder. MC is caused by variants in the voltage‐gated chloride channel 1 ( CLCN1 ) gene, important for the normal repolarization of the muscle action potential. More than 250 disease‐causing variants in the CLCN1 gene have been reported. This study provides an MC genotype–phenotype spectrum in a large cohort of Greek patients and focuses on novel variants and disease epidemiology, including additional insights for the variant CLCN1:c.501C > G.

Methods

Sanger sequencing for the entire coding region of the CLCN1 gene was performed. Targeted segregation analysis of likely candidate variants in additional family members was performed. Variant classification was based on American College of Medical Genetics (ACMG) guidelines.

Results

Sixty‐one patients from 47 unrelated families were identified, consisting of 51 probands with Becker MC (84%) and 10 with Thomsen MC (16%). Among the different variants detected, 11 were novel and 16 were previously reported. The three most prevalent variants were c.501C > G, c.2680C > T, and c.1649C > G. Additionally, c.501C > G was detected in seven Becker cases in‐cis with the c.1649C > G.

Discussion

The large number of patients in whom a diagnosis was established allowed the characterization of genotype–phenotype correlations with respect to both previously reported and novel findings. For the c.501C > G (p.Phe167Leu) variant a likely nonpathogenic property is suggested, as it only seems to act as an aggravating modifying factor in cases in which a pathogenic variant triggers phenotypic expression.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Myotonia CongenitaChloride ChannelsGenotypeHumansFemaleMaleGreeceAdultMiddle AgedCohort StudiesYoung AdultAdolescentChildAgedMutationChild, PreschoolGenetic Association StudiesPhenotype

Stichwörter der Autor:innen

BeckerCLCN1Thomsenc.501C > Ggenetic modifiermyotonia congenita

Substanzen

Chloride ChannelsCLC-1 channel

Autor:innen und Institutionen

  • Laboratory of Medical Genetics, Medical School, St. Sophia's Children's Hospital, National and Kapodistrian University of Athens, Athens, Greece.
  • Research University Institute for the Study and Prevention of Genetic and Malignant Disease of Childhood, St. Sophia's Children's Hospital, National and Kapodistrian University of Athens, Athens, Greece.
  • Department of Neurology, Eginition Hospital, Medical School, National and Kapodistrian University of Athens, Athens, Greece.
  • Department of Neurology, School of Medicine, University of Patras, Rio-Patras, Greece.
  • First Department of Pediatrics, Medical School, St. Sophia's Children's Hospital, National and Kapodistrian University of Athens, Athens, Greece.
  • Department of Pediatrics, School of Medicine, Aristotle University of Thessaloniki, University General Hospital AHEPA, Thessaloniki, Greece.

ORCID-Profile: Nikolaos M Marinakis, Maria Svingou, Giorgos-Konstantinos Papadimas, Elisabeth Chroni, Joanne Traeger-Synodinos, Kyriaki Kekou

Zitieren

APA

Marinakis, N. M., Svingou, M., Papadimas, G. K., Papadopoulos, C., Chroni, E., Pons, R., Pavlou, E., Sarmas, I., Kosma, K., Apostolou, P., Sofocleous, C., Traeger-Synodinos, J., & Kekou, K. (2024). Myotonia congenita in a Greek cohort: Genotype spectrum and impact of the CLCN1 :c. 501C > G variant as a genetic modifier. Muscle & Nerve. https://doi.org/10.1002/mus.28180

Vancouver

Marinakis NM, Svingou M, Papadimas GK, Papadopoulos C, Chroni E, Pons R, et al. Myotonia congenita in a Greek cohort: Genotype spectrum and impact of the CLCN1 :c. 501C > G variant as a genetic modifier. Muscle & Nerve. 2024. doi:10.1002/mus.28180

BibTeX
@article{Marinakis2024,
  author = {Marinakis, Nikolaos M and Svingou, Maria and Papadimas, Giorgos-Konstantinos and Papadopoulos, Constantinos and Chroni, Elisabeth and Pons, Roser and Pavlou, Evangelos and Sarmas, Ioannis and Kosma, Konstantina and Apostolou, Paraskevi and Sofocleous, Christalena and Traeger-Synodinos, Joanne and Kekou, Kyriaki},
  title = {Myotonia congenita in a Greek cohort: Genotype spectrum and impact of the CLCN1 :c. 501C > G variant as a genetic modifier},
  journal = {Muscle & Nerve},
  year = {2024},
  doi = {10.1002/mus.28180}
}
Kostenlos starten →